Public Health Policies and Pharmaceutical Sovereignty Through The Prism of Investment Agreements in the Asia-Pacific Region

Pubblicato online: 15 mag 2025

Pagine: 1 - 13

Ricevuto: 29 nov 2024

Accettato: 18 mar 2025

DOI: https://doi.org/10.2478/vjls-2025-0001

Parole chiave

industry relocation, Covid-19 crisis, pharmaceutical sovereignty, new policies, state’s aid, investment treaties, investments international mobility, states international obligations

© 2025 Sebastien Manciaux., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.